HopeStage
Back to overview

Anxiety studies

Topics
More filters

Anxiety

Anxiety conditions involve intense, persistent fears or worries that can interfere with everyday life.

5111studies shown
Showing 853-864 of 5,111
Drug study icon
CompletedNCT05571592

Cannabidiol as a Treatment for Social Anxiety Disorder (R61)

Official study title

Randomized Placebo-controlled Trial to Determine the Biological Signature of Cannabidiol as a Treatment for Social Anxiety Disorder (R61)

This study has finished and is no longer accepting participants.

In New York
AnxietyMedication studyAges 18–45
Countries
United States
Sponsor
NYU Langone Health
Drug study icon
CompletedNCT06693609

Exploratory Safety and Efficacy of EMP-01 in Social Anxiety Disorder

What is this study about?

Researchers compared EMP-01 and placebo, tracking side effects to assess safety and tolerability in adults with an anxiety condition.

This study has finished and is no longer accepting participants.

Multiple locations, including Bridgetown
AnxietyMedication studyAges 18–65
Countries
United Kingdom
Sponsor
atai Therapeutics, Inc.
Drug study icon
Active Not RecruitingNCT06615557

Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)

Official study title

US, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial of Fasedienol Nasal Spray for the Acute Treatment of Anxiety Induced by a Public Speaking Challenge in Adult Subjects With Social Anxiety Disorder, With an Open-Label Extension (PALISADE-4)

This study is no longer accepting new participants.

Multiple locations, including Phoenix
AnxietyMedication studyAges 18–65
Countries
United States
Sponsor
VistaGen Therapeutics, Inc.
Drug study icon
CompletedNCT06145490

Neurobehavioral Correlates of Caffeine on Anxiety, Avoidance and Interoception in Healthy Individuals and Panic Disorder.

Official study title

Adenosine Receptors From Genes to Behavior: Neurobehavioral Correlates of Caffeine on Anxiety, Avoidance, Decision-Making and Interoception in Healthy Individuals and Panic Disorder.

This study has finished and is no longer accepting participants.

Multiple locations, including Lund
AnxietyPlacebo researchAges 18–65
Countries
Sweden
Sponsor
Uppsala University
Behavioral study icon
CompletedNCT03821779

Prefrontal Oscillations in Social Anxiety Disorder (POSAD)

Official study title

Study of Slow Prefrontal Cortex Oscillations During Social Exposure in Social Anxiety Disorder

This study has finished and is no longer accepting participants.

In Bordeaux
AnxietyStudy assessmentsAges 20–50
Countries
France
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Behavioral study icon
CompletedNCT07464561

RESCCUE4 - Group CBT for Social Anxiety in Adolescents

Official study title

REcover Spaces for Traumatized Children in CommUnity sEttings Post COVID-19 (RESCCUE4): A Double-Blind Controlled Trial Comparing Group Cognitive Behavioral Therapy Versus Treatment as Usual in Adolescents With Social Anxiety Disorder

This study has finished and is no longer accepting participants.

In Roma
AnxietyBehavioural studyAges 12–17
Countries
Italy
Sponsor
Bambino Gesù Hospital and Research Institute
Drug study icon
Active Not RecruitingNCT07221578

VQW-765 for anxiety

What is this study about?

Researchers are comparing VQW-765 and placebo, tracking side effects to assess safety in people with an anxiety condition.

This study is no longer accepting new participants.

Multiple locations, including Phoenix
AnxietyMedication studyAges 18–65
Countries
United States
Sponsor
Vanda Pharmaceuticals
Behavioral study icon
CompletedNCT07299045

The Impact of Mindfulness-Based Psychoeducation on Perceived Stress, Intolerance of Uncertainty, and Cognitive Flexibility in people with Anxiety Disorders

Official study title

The Impact of Mindfulness-Based Psychoeducation on Perceived Stress, Intolerance of Uncertainty, and Cognitive Flexibility in Patients With Anxiety Disorders: A Randomized Controlled Trial

This study has finished and is no longer accepting participants.

In Aydin
AnxietyInterventional studyAges 18–80
Countries
Türkiye
Sponsor
Aydin Adnan Menderes University
Other study type icon
CompletedNCT05964231

The Intervention of Psychobiotics in people with Anxiety Disorders

Official study title

A Double-blind Randomized Controlled Trial Investigating Associations of Microbiota, Serum Total Antioxidant Capacity and Sleep or Psychiatric Symptoms Before and After the Intake of Psychobiotic Lactobacillus Paracasei

This study has finished and is no longer accepting participants.

In Taipei
AnxietyPlacebo comparisonAges 20–70
Countries
Taiwan
Sponsor
Mackay Memorial Hospital

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.